First results from the CAROLINA outcomes trial comparing linagliptin and glimepiride will be presented at 4:30 p.m. Monday in W-3001 (West, Level 3). Julio Rosenstock, MD, CAROLINA principal investigator, talked to ADAMeetingNews.org about the significance of the trial.
Beginning soon: The CAROLINA Trial—First Results of the Cardiovascular Outcomes Trial Comparing Linagliptin vs. Glimepiride
Julio Rosenstock, MD
